Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Archer-Daniels-Midland CoADM · Entity 3077 | Director | October 01, 2026 | October 05, 2026 |
| Elanco Animal Health IncELAN · Entity 3457 | SEE REMARKS | April 01, 2026 | April 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Archer-Daniels-Midland Co
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 11,804.402 |
Reported balance
After 2026-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 721.591 · Balance 11,804.402 F1: Represents stock units credited under the dividend equivalent reinvestment provision of the Archer-Daniels-Midland Company Stock Unit Plan for Nonemployee Directors. F2: Conversion or exercise price of Derivative Security is 1-for-1. F3: The earlier of (i) the date five years after the end of the calendar year (a) that includes the calendar quarter for which any stock unit is awarded to the participant or (b) in which such stock unit is credited to the participant as a dividend equivalent or (ii) the date the participant ceases to be a member of the Board of Directors, in each case as may be extended pursuant to the terms of the Archer-Daniels-Midland Company's Stock Unit Plan for Nonemployee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents stock units credited under the dividend equivalent reinvestment provision of the Archer-Daniels-Midland Company Stock Unit Plan for Nonemployee Directors.
F2: Conversion or exercise price of Derivative Security is 1-for-1.
F3: The earlier of (i) the date five years after the end of the calendar year (a) that includes the calendar quarter for which any stock unit is awarded to the participant or (b) in which such stock unit is credited to the participant as a dividend equivalent or (ii) the date the participant ceases to be a member of the Board of Directors, in each case as may be extended pursuant to the terms of the Archer-Daniels-Midland Company's Stock Unit Plan for Nonemployee Directors.
Elanco Animal Health Inc
Report date April 01, 2026 · Filed April 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 280,821 |
Ending reported balance
After 2026-04-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-04-01 · Grant · Acquired 40,985 · Balance 301,109 Row 2 · 2026-04-01 · Tax withholding · Disposed 20,288 · Balance 280,821 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2022 Filed Mar 4, 2022 01:58 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option(right to buy) · Derivative | 38,522 | $0.00 Strike: $28.94 | $0.00 |
DisclosureSEC source: 0001415889-22-002467 · form4-03032022_050334.xml · derivative · entry 2 de Brabander Ellen · CIK 0001892179 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,522 Underlying: Common Stock · 38,522 shares Expires 2032-03-01 F2 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:58 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 14,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002467 · form4-03032022_050334.xml · nonDerivative · entry 1 de Brabander Ellen · CIK 0001892179 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,131 F1 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025. Read SEC document |
| November 01, 2021 Filed Nov 8, 2021 21:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 45,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-009929 · edgar.xml · nonDerivative · entry 1 de Brabander Ellen · CIK 0001892179 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,635 F1 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on November 1, 2021, one-half vesting on November 1, 2022 and the remaining half vesting on November 1, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.